453 related articles for article (PubMed ID: 34063568)
21. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Sinha A; Ignatchenko V; Ignatchenko A; Mejia-Guerrero S; Kislinger T
Biochem Biophys Res Commun; 2014 Mar; 445(4):694-701. PubMed ID: 24434149
[TBL] [Abstract][Full Text] [Related]
22. Identification and validation of differentially expressed proteins in epithelial ovarian cancers using quantitative proteomics.
Qu H; Chen Y; Cao G; Liu C; Xu J; Deng H; Zhang Z
Oncotarget; 2016 Dec; 7(50):83187-83199. PubMed ID: 27825122
[TBL] [Abstract][Full Text] [Related]
23. Targeted mass spectrometry approaches for protein biomarker verification.
Meng Z; Veenstra TD
J Proteomics; 2011 Nov; 74(12):2650-9. PubMed ID: 21540133
[TBL] [Abstract][Full Text] [Related]
24. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
[TBL] [Abstract][Full Text] [Related]
25. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
26. Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.
Pernikářová V; Bouchal P
Expert Rev Proteomics; 2015; 12(6):651-67. PubMed ID: 26456120
[TBL] [Abstract][Full Text] [Related]
27. Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
Bonifácio VDB
Adv Exp Med Biol; 2020; 1219():355-363. PubMed ID: 32130708
[TBL] [Abstract][Full Text] [Related]
28. Quantitative assessment of serum heat shock protein 27 for the diagnosis of epithelial ovarian cancer using targeted proteomics coupled with immunoaffinity enrichment.
Yang T; Xu P; Gu L; Xu Z; Ge W; Li Q; Xu F
Clin Chim Acta; 2019 Feb; 489():96-102. PubMed ID: 30502327
[TBL] [Abstract][Full Text] [Related]
29. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer.
McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A
BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763
[TBL] [Abstract][Full Text] [Related]
30. Detection of Epithelial Ovarian Cancer using C8Magnetic Bead Separation and MALDI-TOF Plasma Proteome Profiling in Egyptian Females.
Rizk MM; Sharaki OA; Meleis ME; Younan DN; Elkial AA; Moez P
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3603-3609. PubMed ID: 31870100
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets.
Boyce EA; Kohn EC
Int J Gynecol Cancer; 2005; 15 Suppl 3():266-73. PubMed ID: 16343243
[TBL] [Abstract][Full Text] [Related]
32. Clinical application of proteomics in ovarian cancer prevention and treatment.
Meani F; Pecorelli S; Liotta L; Petricoin EF
Mol Diagn Ther; 2009; 13(5):297-311. PubMed ID: 19791834
[TBL] [Abstract][Full Text] [Related]
33. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
[TBL] [Abstract][Full Text] [Related]
35. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
[TBL] [Abstract][Full Text] [Related]
36. Emerging Protein Biomarkers in Epithelial Ovarian Cancer Prognosis: An Aid for Multivariate Indexing.
Paliwal P; Ranade H; Desai D; Datta M
Curr Protein Pept Sci; 2021; 22(7):505-513. PubMed ID: 33568031
[TBL] [Abstract][Full Text] [Related]
37. Predictive modeling in proteomics-based disease detection.
Pham TD
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3308-11. PubMed ID: 18002703
[TBL] [Abstract][Full Text] [Related]
38. Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery.
Swiatly A; Horala A; Matysiak J; Hajduk J; Nowak-Markwitz E; Kokot ZJ
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065196
[TBL] [Abstract][Full Text] [Related]
39. Proteomics and biomarkers for ovarian cancer diagnosis.
Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer.
Gunawardana CG; Kuk C; Smith CR; Batruch I; Soosaipillai A; Diamandis EP
J Proteome Res; 2009 Oct; 8(10):4705-13. PubMed ID: 19663500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]